Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Donnellan

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Melanoma Research|July 29, 2003
A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanomaS Nicholson, K Guile, J John, et al.
Irish Medical Journal|May 25, 2026
It's Time for Ireland's Tobacco-Free FutureJ Gannon, M Heffron, D W Cox, et al.
Irish Journal of Medical Science|November 5, 2014
A review of sentinel lymph node biopsy for thin melanomaK M Joyce, N M McInerney, C W Joyce, et al.
Gynecologic Oncology|December 15, 2019
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS)F T Roncolato, R L O'Connell, F Joly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trialSandra M Swain, Gong Tang, Charles E Geyer, et al.
Melanoma Research|March 10, 2015
High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patientsKarin van den Hurk, Balazs Balint, Sinead Toomey, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Melanoma Research|July 29, 2003
A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanomaS Nicholson, K Guile, J John, et al.
Irish Medical Journal|May 25, 2026
It's Time for Ireland's Tobacco-Free FutureJ Gannon, M Heffron, D W Cox, et al.
Irish Journal of Medical Science|November 5, 2014
A review of sentinel lymph node biopsy for thin melanomaK M Joyce, N M McInerney, C W Joyce, et al.
Gynecologic Oncology|December 15, 2019
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS)F T Roncolato, R L O'Connell, F Joly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trialSandra M Swain, Gong Tang, Charles E Geyer, et al.
Melanoma Research|March 10, 2015
High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patientsKarin van den Hurk, Balazs Balint, Sinead Toomey, et al.
Pageof 3